Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

AstraZeneca signs $200m deal with Bind for cancer drug

Follows deals with Amgen and Pfizer for Bind involving its Accurin nanotechnology

- PMLiVE

Roche faces another NICE rejection for Avastin

Draft guidance turns down drug for use in ovarian cancer

- PMLiVE

Ipsos promotes Jackie Ilacqua to global head of syndicated services

Will retain role as president of global oncology

- PMLiVE

Adapt and overcome: Adaptive trial design in research

The pharma industry is slowly starting to embrace adaptive trial design, though not as quickly as once hoped, thanks largely to regulatory uncertainty

- PMLiVE

FDA stung by damning fraudulent research report

Agency accused of leaving untested drugs on the market

Covance expands its clinical trials capabilities across Asia Pacific

New laboratory doubles CRO’s genomics footprint in Singapore

Lilly ramps up social media use

Next phase of LillyPad blog expansion aims at journalists

- PMLiVE

GSK accused of delaying generic Seroxat in UK

Could be fined 10 per cent of global turnover if found to have infringed competition law

- PMLiVE

US shortage of GSK’s restless legs syndrome treatment Horizant

FDA blames contract manufacturer delays

- PMLiVE

Former FDA adviser joins Precision for Medicine

Vicki Seyfert-Margolis appointed chief of science and strategy at life science research company

- PMLiVE

The life of Alice Keller – one of the first female pharma execs

This month in 1896: Birth of Alice Keller who became one of the first female execs in the pharma indsutry during her time at Roche

- PMLiVE

New IPA president Ian Priest puts commercial creativity at the core of his agenda

Commences his two-year presidency with push for bottom line in ‘always on’ marketing environment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links